Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000568 Compositions and methods for detecting EGFR in cancer

Patent 10000568 was granted and assigned to Cell Signaling Technology on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Cell Signaling Technology

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100005680

Patent Inventor Names

Victoria Rimkunas0

Jun-Ming Cai0

Susan Kane0

Ting-Lei Gu0

Herbert Haack0

James Wieler0

Jian Yu0

Jiong Wu0

Date of Patent

June 19, 2018

Patent Application Number

124504570

Date Filed

April 10, 2009

Patent Primary Examiner

‌

Michael Pak

Patent abstract

The invention discloses binding agents to the E746-A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule, and methods for use thereof, including methods for the diagnosis and treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000568 Compositions and methods for detecting EGFR in cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API